Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H
- 1 September 1995
- journal article
- case report
- Published by Springer Nature in Eye
- Vol. 9 (5) , 564-569
Abstract
We report a patient with peripheral rheumatoid corneal melting who developed a corneal perforation in one eye requiring tectonic keratoplasty. Nine consecutive corneal grafts were rapidly destroyed despite systemic immunosuppression with corticosteroid, cyclophosphamide, azathioprine and cyclosporin A. A rejection episode was observed in one graft before it melted and allograft rejection may have contributed to the destruction of other grafts. Corneal graft survival was ultimately achieved by systemic immunosuppression with the anti-lymphocyte monoclonal antibody, CAM-PATH-1H. A single episode of rejection developed in the early post-operative period which was easily reversed by topical corticosteroid. Corneal melting has not recurred and the graft has now remained intact and clear for 24 months. Anti-lymphocyte monoclonal antibodies may therefore provide effective immunosuppression in the treatment of refractory ocular disorders.Keywords
This publication has 22 references indexed in Scilit:
- Graft Failure in KeratoepithelioplastyCornea, 1993
- Reprogramming the Immune System for Peripheral Tolerance with CD4 and CD8 Monoclonal AntibodiesImmunological Reviews, 1992
- Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody.British Journal of Ophthalmology, 1992
- PATTERNS OF CORNEAL GRAFT REJECTION IN THE RABBIT AND REVERSAL OF REJECTION WITH MONOCLONAL ANTIBODIESTransplantation, 1992
- Tectonic Keratoplasty for Peripheral Ulcerative KeratitisCornea, 1991
- The induction of skin graft tolerance in major histocompatibility complex‐mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti‐CD4 and anti‐CD8 antibodiesEuropean Journal of Immunology, 1990
- The CAMPATH‐1 antigen (CDw52)Tissue Antigens, 1990
- ‘Pulsed’ immunosuppressive therapy in the treatment of immunologically induced corneal and scleral diseaseEye, 1987
- Ulceration of the cornea in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1977
- PREVENTION OF CORNEAL-GRAFT FAILURE WITH THE IMMUNOSUPPRESSIVE DRUG AZATHIOPRINEThe Lancet, 1967